Join to View Full Profile
550 Peachtree St NEAtlanta, GA 30308
Phone+1 404-778-1900
Fax+1 404-778-3002
Dr. Yushak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2009 - 2012
University of Vermont College of MedicineClass of 2009
Certifications & Licensure
GA State Medical License 2015 - 2025
CT State Medical License 2012 - 2015
MA State Medical License 2009 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery Start of enrollment: 2018 Jan 31
Roles: Contact
Publications & Presentations
PubMed
- The diagnostic challenges of differentiating metastatic extramammary Paget disease and prostatic adenocarcinoma: A case report and review of the literature.Gregory Palmateer, Edouard H Nicaise, Jatin Gandhi, Taylor Goodstein, Michelle Sheng
Urology Case Reports. 2024-11-01 - 9 citationsPhase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma.Omid Hamid, Karl D Lewis, Amy Weise, Meredith McKean, Kyriakos P Papadopoulos
Journal of Clinical Oncology. 2024-08-20 - 1 citationsTregs protect against combination checkpoint blockade toxicity induced by Tph and B cell interactions.Alyssa Duffy, Maryam I Azeem, Smriti Kanangat, Melinda Yushak, David Lawson
The Journal of Clinical Investigation. 2024-05-02
Press Mentions
Most Cancer Patients Want Tumor Profiling, Even if It Reveals Other Genetic RisksApril 21st, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
